CLFD Form 4: CEO Cheryl Beranek receives PSUs, withholds shares
Rhea-AI Filing Summary
Clearfield, Inc. (CLFD) reported an insider equity transaction for its Chief Executive Officer and director, Cheryl Beranek. On 11/20/2025, she acquired 5,393 shares of common stock at $0 per share upon the vesting of performance stock units, increasing her directly held common shares to 480,111.
On the same date, she also received 10,788 shares of restricted stock at $0 per share upon the vesting of performance stock units, bringing her restricted stock holdings to 490,899 shares. The restricted stock is scheduled to vest in two equal installments on November 16, 2026 and November 16, 2027.
To cover taxes on vesting, 2,653 shares of common stock were disposed of at $28.22 per share through share withholding, leaving Beranek with 488,246 shares of common stock held directly after the reported transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,393 | $0.00 | -- |
| Grant/Award | Restricted Stock | 10,788 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,653 | $28.22 | $75K |
Footnotes (1)
- Represents the number of shares of common stock issued upon vesting of performance stock units. Represents the number of shares of restricted stock issued upon the vesting of performance stock units. The restricted stock vests as to one-half of the shares on November 16, 2026 and November 16, 2027. Payment of taxes by withholding shares on the vesting of one-third of performance stock units.
FAQ
What insider transaction did Clearfield (CLFD) report for Cheryl Beranek?
Clearfield reported that CEO and director Cheryl Beranek acquired 5,393 shares of common stock and 10,788 shares of restricted stock on 11/20/2025 from the vesting of performance stock units.
What is the vesting schedule for the new Clearfield (CLFD) restricted stock?
The 10,788 shares of restricted stock issued to Cheryl Beranek vest in two equal installments, with one-half vesting on November 16, 2026 and the other half on November 16, 2027.
What triggered the new Clearfield (CLFD) stock grants reported on this Form 4?
The filing explains that the 5,393 common shares and 10,788 restricted shares represent stock issued upon the vesting of performance stock units previously awarded to Cheryl Beranek.
Is this Clearfield (CLFD) Form 4 filed for one reporting person or a group?
The Form 4 is indicated as being filed by one reporting person, covering transactions for Cheryl Beranek only.